Skip to main content

Indivior Pharmaceuticals, Inc.

INDV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001625297

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Indivior Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
116
+4 vs. Q4 2024
Shares held
91.3M
+13.6M (+17.6%) vs. Q4 2024
Total value
$866.0M
−$107.6M (−11.1%) vs. Q4 2024
New holders
25
34 more added
Sold out
21
41 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INDV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 116 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 60 institutionsQ3 2023: 76 institutionsQ4 2023: 76 institutionsQ1 2024: 95 institutionsQ2 2024: 99 institutionsQ3 2024: 103 institutionsQ4 2024: 113 institutionsQ1 2025: 116 institutionsQ2 2025: 120 institutionsQ3 2025: 198 institutionsQ4 2025: 259 institutionsQ1 2026: 290 institutionsQ2 2026: 337 institutions
Value heldQ1 2025: $866.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $1.46BQ3 2023: $1.53BQ4 2023: $974.7MQ1 2024: $1.38BQ2 2024: $1.03BQ3 2024: $720.7MQ4 2024: $974.8MQ1 2025: $866.0MQ2 2025: $1.58BQ3 2025: $2.68BQ4 2025: $4.36BQ1 2026: $3.89BQ2 2026: $4.98B
Institutions holding INDV and their total value by quarter
QuarterHoldersValue
Q2 2026337$4.98B
Q1 2026290$3.89B
Q4 2025259$4.36B
Q3 2025198$2.68B
Q2 2025120$1.58B
Q1 2025116$866.0M
Q4 2024113$974.8M
Q3 2024103$720.7M
Q2 202499$1.03B
Q1 202495$1.38B
Q4 202376$974.7M
Q3 202376$1.53B
Q2 202360$1.46B
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Indivior Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding INDV in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC1,342,481$12.8M0.01%+570,101+73.8%Added
Jefferies Financial Group Inc.1,481,333$13.9M0.24%−153,770−9.4%Reduced
Newtyn Management, LLC1,650,938$15.7M2.49%+244,407+17.4%Added
Scopia Capital Management LP1,875,108$17.9M2.59%+391,984+26.4%Added
Point72 Asset Management, L.P.1,886,231$18.0M0.05%+1,886,231New
Susquehanna International Group, LLP2,271,942$21.7M0.04%+2,050,248+924.8%Added
Millennium Management LLC2,465,714$23.5M0.02%+1,232,708+100.0%Added
UBS Group AG3,527,279$33.6M0.01%+2,694,468+323.5%Added
Rubric Capital Management LP3,530,039$33.6M0.60%+2,170,039+159.6%Added
Vanguard Group Inc4,631,221$43.8M0.00%+71,539+1.6%Added
Madison Avenue Partners, LP7,792,089$74.3M6.30%+4,118,663+112.1%Added
Goldman Sachs Group Inc8,368,996$79.8M0.02%+1,299,425+18.4%Added
Deerfield Management Company, L.P. (Series C)10,567,160$100.7M2.00%+1,684,000+19.0%Added
Oaktree Capital Management LPSuperinvestorOaktree Capital11,009,125$103.5M2.10%+2,275,577+26.1%Added
Two Seas Capital LP11,366,777$106.5M16.56%−1,090,737−8.8%Reduced
Bank of Montreal864––00.0%Unchanged
Liontrust Investment Partners LLP0$00.00%−1,326,647−100.0%Sold out
Rokos Capital Management LLP0$00.00%−500,032−100.0%Sold out
Foursixthree Capital LP0$00.00%−373,231−100.0%Sold out
HighVista Strategies LLC0$00.00%−142,634−100.0%Sold out
M&G Plc0$00.00%−110,039−100.0%Sold out
Melqart Asset Management (UK) Ltd0$00.00%−104,790−100.0%Sold out
Trexquant Investment LP0$00.00%−95,893−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−54,057−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−52,662−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−45,478−100.0%Sold out
Man Group plc0$00.00%−45,365−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−25,391−100.0%Sold out
Gotham Asset Management, LLC0$00.00%−26,121−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−21,700−100.0%Sold out
JustInvest LLC0$00.00%−14,825−100.0%Sold out
Stifel Financial Corp0$00.00%−12,675−100.0%Sold out
Pale Fire Capital SE0$00.00%−10,001−100.0%Sold out
Simplex Trading, LLC0$00.00%−4,703−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−1,840−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−252−100.0%Sold out
FMR LLC0$00.00%−205−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed